Caregiver, Clinical Research Coordinator with medical assistant skills
Resume:
KENYETTA M. GRAYER
**** **** ****** ****, *** 29, Rosamond, CA 93560
**************@*****.***
Objective
Highly motivated and compassionate care giver, clinical research coordinator and medical assistant with a strong background and patient care and research. Seeking an entry-level position and behavioral therapies and related fields of psychology to leverage my dedication and skills. Eager to join a compassionate team committed to providing exceptional services to those in need of behavioral therapy, striving to make a positive impact on their lives through diligence and empathetic care.
Skills
• Motivated self-starter • Informed consent adequacy
• Ability to work in a fast-paced environment • Excellent inventory manager
• Able to handle unsupervised work • Microsoft suite proficiency
• Professional and mature • Recruitment and advertisement
• Positive attitude • Publish source documents
• Detail-oriented • Manage multiple studies
• Efficient communicator • Patient advocate
Certifications
• BLS/ First Aid
• HIPAA
• National Certified Medical Assistant Certification (exam pending June 2017)
• Trained Phlebotomist
• CITI Certified in ICH GCP Guidelines
• IATA Certification in Handling and Shipping of Dangerous Goods
• Certified in most commonly used EDC and IXRS systems used by Sponsors & CRO’s Education
Bachelor of Science in Applied Psychology
Bachelor of Arts in Biblical Studies
Colorado Christian University
Completion Date: May 2025
Lakewood, CO
Certificate in Clinical Medical Assisting
San Joaquin Valley College
Completed: April 2016 Lancaster, CA
Associate of Science in Natural Science/Math
Associate of Arts in Social Science
Associate of Arts in Humanities
Barstow Community College
Completed: May 2014 Barstow, CA
Employment Experience
2
In-Home Supportive Services
Lancaster, CA
Caregiver
05/2024-
Provide essential support and care to individuals in their homes. Offer personalized assistance to help clients maintain their independence and improve the quality of life, while providing physical and emotional care, with an eagerness to make a positive impact on the lives of others. Synergist Research LLC
Lancaster, CA
Clinical Research Coordinator 03/2016 -03/2017
Implementation of best practices, policies and procedures for conducting clinical research in an ethical and effective way, following good clinical practice and the guidelines provided from the International Conference on Harmonization. Providing all necessary FDA required regulatory reports and documentation for ongoing studies, devising patient recruitment and advertising campaigns, and follow-up for subjects participating in research studies, and management of all personnel involved in the treatment of study subjects. Assist the Principal Investigator in his requirement to remain up to date on all changes within the current studies, and to meet all FDA and Sponsor requirements for quality clinical research.
Barstow Community College Barstow, CA
Access Secretary 06/2012-05/2014
• Data entry into the college data base • Mastery in telephone etiquette
• Set appointments for the assistant director as well as students
• Taking inventory of all supplies within the office
• Confirmation calls to confirm appointments • Assist students with disabilities and training for the use of certain equipment
• Compose emails in house and to the public • Creating New Documents
• Filing confidential documents and maintaining
student confidentiality
• Work with multiple departments
• Faxing doctors to receive patient information • Convert books to PDF format
• Microsoft Suite • Assist with New Student Orientations PREVIOUS CLINICAL RESEARCH STUDIES
Synergy Pharmaceuticals
SP304203-04 (IBS-C Study)
A Randomized, 14-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients with Irritable Bowel Syndrome with Constipation SP304203-06 (IBS-C Study)
An Open-Label, Long-Term Safety and Tolerability Study of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Hologic
V10434-HBVQPS-CSP-01 (Hepatitis B)
Collection of Plasma Samples from Individuals Initiating Therapy with Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay 3
Prometheus
15IBS01 (Chronic Diarrhea)
Procurement of Blood, and Stool from Subjects with Symptoms of Chronic Diarrhea for use in the development of a Gastrointestinal Disease Test
Braeburn Pharmaceuticals
HS-11-421 (Opioid Dependence)
A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multi-center Trial Assessing the Efficacy and Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Treatment of Adult Outpatients with Opioid Use Disorder Amarin Pharma Inc.
AMR-01-01-0019
A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Ca Ardelyx, Inc.
TEN-01-302
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Celgene Corporation
GED-0301-CD-002
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of Mongersen (GED-0301) for the treatment of subjects with active Crohn’s Disease
RPC01-3101
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis RPC01-3102
A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Eisai Inc.
E5501-G000-310
A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults with Thrombocytopenia Associated with Liver Disease Prior to an Elective Procedure Prometheus Therapeutics & Diagnostics
16GI01
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of a 12-week Add-on Treatment with LT-02 (Delayed Release Phosphatidylcholine Granules) vs. Placebo in Subjects with Ulcerative Colitis Refractory to Standard Treatment with Mesalamine Followed by 4
an Optional 24-week Open-Label Active Drug Dosing Period
Contact this candidate